조주연 교수

소화기내과

조주연 교수

간염(바이러스, 알코올, 지방간), 간경변증, 간세포암

진료예약
구분
오전
오후


경력 및 학회활동

  • 2020.09- 현재 조선대병원 소화기내과 부교수
  • 2015.09-2020.08 조선대병원 소화기내과 조교수
  • 2015.03-2015.08 조선대병원 소화기내과 전임의
  • 2012.03-2015.02 삼성서울병원 소화기내과 전임의
  • 2008.03-2012.02 조선대병원 내과 레지던트
  • 대한내과학회, 대한간학회, 대한간암학회, 대한소화기학회, 소화기내시경학회 정회원

논문저서

  • 1.Cho JY, Paik YH, Sohn W, Cho HC, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease. Gut. 2014;12:1943-1950. (SCI IF 13.319)
  • 2.Sinn DH, Cho JY(co-author), Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Different survival of Barcelona clinic liver cancer stage C hepatocellular carcinoma patients by the extent of portal vein invasion and the type of extrahepatic spread. PLoS One. 2015;10:e0124434 [Epub ahead of print]
  • 3.Cho JY, Paik YH, Park HC, Yu JI, Sohn W, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. The feasibility of combined transcatheter arterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma. Liver Int. 2014;34:795-801. (SCI IF 4.412)
  • 4.Yu JI, Cho JY(co-author), Park HC, Lim Do H, Gwak GY, Paik SW. Child-Pugh score maintenance in cirrhotic hepatocellular carcinoma patients after radiotherapy:aspectis of gastroduodenal complications. Tumor. 2014;100:645-51. (SCI IF 1.09)
  • 5.Cho JY, Paik YH, Lim HY, Min YW, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Clinical parameters predictive of outcomes in sorafenib-treated patients with advanced hepatocellular carcinoma. Liver Int. 2013;33:950-7. (SCI IF 3.870)
  • 6.Cho JY, Kim DM, Kwon YE, Yoon SH, Lee SI. Newly formed cystic lesions for the development of pneumomediastinum in Pneumocystis jirovecii pneumonia. BMC Infect Dis 2009 Oct. 18;9:171 (SCIE IF 2.55)
  • 7.Ha JM, Sohn W, Cho JY, Pyo JH, Choi K, Sinn DH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC, Paik YH. Static and dynamic prognostic factors for hepatitis-B-related acute-on-chronic liver failure. Clin Mol Hepatol 2015;21:232-41.
  • 8.Sohn W, Kim J, Kang SH, Yang SR, Cho JY, Cho HC, Shim SG, Paik YH. Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma. Exp Mol Med. 2015 [Epub ahead of print]
  • 9.Kim HJ, Cho JY, Kim YJ, Gwak GY, Paik YH, Choi MS, Koh KC, Paik SW, Yoo BC, Lee JH. Long-term efficacy of tenofovir disoproxil fumarate therapy after multiple nucleos(t)ide analogue failure in chronic hepatitis B patients. Korean J Intern Med. 2015;30:32-41.
  • 10.Sohn W, Paik YH, Cho JY, Lim HY, Ahn JM, Sinn DH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Sorafenib therapy for hepatocellular carcinoma with extrahepatic spread: treatment outcome and prognostic factors. J Hepatol [Epub ahead of print] (SCI IF 10.401)
  • 11.Ahn JM, Paik YH, Min SY, Cho JY, Sohn W, Sinn DH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC. Relationship between Controlled Attenuation Parameter and Hepatic steatosis as assessed by ultrasound in alcoholic or nonalcoholic fatty liver disease. Gut Liver 2015. [Epub ahead of print]